发明名称 |
Methods and uses relating to the identification of compound involved in pain as well as methods of diagnosing algesia |
摘要 |
The present invention relates to a method of identifying a compound involved in pain, the use of Ctla2b nucleic acid or Ctla2b protein for identifying a compound involved in pain as well as methods of diagnosing algesia involving the same. |
申请公布号 |
US8835359(B2) |
申请公布日期 |
2014.09.16 |
申请号 |
US201113699976 |
申请日期 |
2011.05.24 |
申请人 |
Sanofi |
发明人 |
Gebauer Mathias;Michaelis Martin;Ding-Pfennigdorff Danping;Schulte Anke M.;Ziemek Daniel;Metz-Weldmann Christiane |
分类号 |
C12Q1/68 |
主分类号 |
C12Q1/68 |
代理机构 |
Lathrop & Gage LLP |
代理人 |
Lathrop & Gage LLP ;Biro, Esq. Michael G. |
主权项 |
1. A method for identifying a compound involved in neuropathic pain comprising the steps of:
a) providing a cell-based system comprising a cytotoxic T lymphocyte-associated protein 2 beta (Ctla2b) nucleic acid encoding a protein comprising the amino acid sequence of either SEQ ID NO: 1 or 2, b) contacting the cell-based system with a test compound, and c) determining an effect of the test compound on the cell-based system, wherein the test compound is identified as a compound involved in neuropathic pain when the test compound causes a statistically significant increase in the level of Ctla2b nucleic acid encoding a protein comprising the amino acid sequence of either SEQ ID NO: 1 or 2 relative to the same cell-based system that was not contacted with the test compound. |
地址 |
Paris FR |